2008
DOI: 10.1016/j.bmc.2008.08.034
|View full text |Cite
|
Sign up to set email alerts
|

Screening of herbal constituents for aromatase inhibitory activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(21 citation statements)
references
References 30 publications
(33 reference statements)
0
21
0
Order By: Relevance
“…Naringenin also inhibits CYP3A4 and CYP19 (Moon et al, 2006). With an IC 50 of 0.34 mM, liquiritigenin has been identified as a potent inhibitor of CYP19 (Paoletta et al, 2008). Inhibitory effects of isosakuranetin on CYP1 enzyme isoforms require concentrations in the range of 1-3 mM (Takemura et al, 2010), and inhibition of other P450 enzymes has, to our knowledge, not been demonstrated.…”
Section: Discussionmentioning
confidence: 86%
“…Naringenin also inhibits CYP3A4 and CYP19 (Moon et al, 2006). With an IC 50 of 0.34 mM, liquiritigenin has been identified as a potent inhibitor of CYP19 (Paoletta et al, 2008). Inhibitory effects of isosakuranetin on CYP1 enzyme isoforms require concentrations in the range of 1-3 mM (Takemura et al, 2010), and inhibition of other P450 enzymes has, to our knowledge, not been demonstrated.…”
Section: Discussionmentioning
confidence: 86%
“…In addition, Gupta et al (2005) reported that A. lebbeck inhibited the fertility of male rats which suppressed the function of Leydig cells and Sertoli cells and inhibited sperm production. Whereas Paoletta et al (2008) noted that the aglycone myricetin inhibits the aromatase enzyme. Also, Lu et al (2012) reported that myricetin inhibited oestrogen biosynthesis by 20%, although it worked via suppressing aromatase transcription rather than inhibiting the enzyme.…”
Section: Discussionmentioning
confidence: 99%
“…Three Potential inhibitors of the human, aromatase enzyme (CYP19) myricetin, liquiritigenin, and gossypetin, were screened by random forest as well as molecular docking studies. The virtual screening results were subsequently confirmed experimentally by in vitro assay [87]. …”
Section: In Silico Methods For Ligand-protein Interactionsmentioning
confidence: 97%